We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

83 hedge funds and large institutions have $294M invested in VanEck Biotech ETF in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

3.59% more ownership

Funds ownership: 41.64% → 45.23% (+3.6%)

2% more funds holding

Funds holding: 81 → 83 (+2)

12% less capital invested

Capital invested by funds: $333M → $294M (-$38.5M)

23% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 26

51% less call options, than puts

Call options by funds: $2.87M | Put options by funds: $5.85M

Holders
83
Holders Change
+2
Holders Change %
+2.47%
% of All Funds
2.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
20
Reduced
26
Closed
11
Calls
$2.87M
Puts
$5.85M
Net Calls
-$2.98M
Net Calls Change
+$1.63M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$17.8M
2
VFAM
Valley Forge Asset Management
Pennsylvania
+$6.31M
3
Truist Financial
Truist Financial
North Carolina
+$4.84M
4
TRCT
Tower Research Capital (TRC)
New York
+$4.68M
5
CS
Credit Suisse
Switzerland
+$3.74M

Top Sellers

Rank Fund Capital Flow
1
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$7.44M
2
UCFA
United Capital Financial Advisors
Texas
-$7.28M
3
UBS Group
UBS Group
Switzerland
-$4.29M
4
ECML
Eagle Capital Management (Louisiana)
Louisiana
-$4.16M
5
Morgan Stanley
Morgan Stanley
New York
-$3.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
BRM
26
Boston Research & Management
Massachusetts
$1.82M +$66.2K +500 +3%
NPC
27
National Planning Corporation
California
$1.57M -$47.3K -357 -3%
Ameriprise
28
Ameriprise
Minnesota
$1.56M -$341K -2,575 -16%
AFG
29
Albion Financial Group
Utah
$1.44M -$103K -781 -6%
WJA
30
Williams Jones & Associates
New York
$1.41M -$533K -4,030 -25%
EDRS
31
Edmond de Rothschild (Suisse)
Switzerland
$1.41M +$693K +5,239 +74%
Bank of America
32
Bank of America
North Carolina
$1.3M -$1.02M -7,685 -40%
Citadel Advisors
33
Citadel Advisors
Florida
$962K +$52K +393 +5%
Stifel Financial
34
Stifel Financial
Missouri
$943K +$59.6K +450 +6%
AIG
35
American International Group
New York
$808K +$108K +819 +13%
HSBC Holdings
36
HSBC Holdings
United Kingdom
$737K +$296K +2,235 +53%
GJIC
37
Gamble Jones Investment Counsel
California
$686K – – –
Millennium Management
38
Millennium Management
New York
$676K +$783K +5,914 New
UCFA
39
United Capital Financial Advisors
Texas
$653K -$7.28M -54,992 -91%
HighTower Advisors
40
HighTower Advisors
Illinois
$618K -$92.7K -700 -11%
MFS
41
MSI Financial Services
Massachusetts
$604K +$353K +2,668 +102%
IAMOG
42
Investors Asset Management of Georgia
Georgia
$423K – – –
JP Morgan Chase
43
JP Morgan Chase
New York
$392K +$20K +151 +5%
Cambridge Investment Research Advisors
44
Cambridge Investment Research Advisors
Iowa
$365K -$131K -990 -24%
ICAS
45
Investors Capital Advisory Services
Massachusetts
$352K +$34.4K +260 +9%
AB
46
Atlas Brown
Kentucky
$348K – – –
First Manhattan
47
First Manhattan
New York
$342K – – –
FAAS
48
First Allied Advisory Services
California
$323K -$53.6K -405 -13%
TH
49
Timber Hill
Connecticut
$313K +$363K +2,742 New
PAG
50
Private Advisor Group
New Jersey
$298K +$345K +2,607 New
1
2
3 4

BBH Hedge Fund Activity: Q3 2015 in Review

83 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2015, worth a combined $294M — down 12% from $333M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BBH positions and 11 closed out — a net gain of 2 holders — while 20 added to existing stakes and 26 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $17.8M. The largest seller was Envestnet Asset Management, cutting an estimated $7.44M.

  • 83 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2015, up from 81 in Q2 2015.
  • Funds reported $294M of VanEck Biotech ETF stock for Q3 2015, down 12% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q3 2015 and 11 closed out, a net change of +2 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2015 was Goldman Sachs, an estimated $17.8M added.
  • The largest VanEck Biotech ETF seller in Q3 2015 was Envestnet Asset Management, an estimated $7.44M sold.

Based on aggregated 13F filings for Q3 2015.